Defilade Capital Management »

Align Technology shares owned by Defilade Capital Management

Quarter-by-quarter ownership of Align Technology (ALGN) shares owned by Defilade Capital Management from 13F filings

Historical chart of Defilade Capital Management investment in Align Technology

Tip: Access up to 7 years of quarterly data

All positions including Align Technology held by Defilade Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Align Technology by Defilade Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $12M 67k 171.43

More positions owned by Defilade Capital Management

Zimmer Holdings (ZBH)
Henry Schein (HSIC)
Becton, Dickinson and (BDX)
Pfizer (PFE)
Dex (DXCM)
ICU Medical, Incorporated (ICUI)
Insmed Com Par $.01 (INSM)
Intuitive Surgical Com New (ISRG)
Revolution Medicines (RVMD)
Globus Med Cl A (GMED)
Neurocrine Biosciences (NBIX)
Denali Therapeutics (DNLI)
Ptc Therapeutics I (PTCT)
Olema Pharmaceuticals (OLMA)
Elanco Animal Health (ELAN)

View all positions for Defilade Capital Management

Top funds holding Align Technology

Vanguard Group
Vanguard Capital Management
BlackRock
Capital World Investors
Capital Research and Management Company - Division 3
Vanguard Portfolio Management
State Street Corporation
Investec Asset Management
FMR
T. Rowe Price Investment Management
Goldman Sachs Group
Geode Capital Management
UBS Group
Invesco
Susquehanna International

View all funds holding Align Technology